Compare evidence by the question it answers
Which compound is best? We can’t get far with that until we know: best at what? A hormone pulse, a skin finding and weight loss are different results.
We compare the questions the research answered. The aim is to make a claim easier to judge, without handing out medals to molecules.
Three results that can’t share a scoreboard
An animal finding
BPC-157 helped stomach ulcers heal in rats. That doesn’t establish injury recovery in a person. The species and the problem tested matter.
A human response
Ipamorelin triggered a growth-hormone pulse. Its later bowel-surgery trial did not establish faster meal recovery. Something changing isn’t the same as someone benefiting.
A mixture result
A GHK-containing scalp mixture increased hair counts. The result can’t tell us what one ingredient did alone. It also can’t establish an injection’s effects.
Each result can be worth reading without answering the same question. NAD+ precursor studies make a similar point: more of something in blood doesn’t by itself establish better health.
A weight trial tests weight change
In a semaglutide weight-management trial, adults with overweight or obesity, without diabetes, lost more weight than those given placebo, a preparation without the active drug. That directly tests a human outcome. It gives a different kind of answer from a repair effect seen in cells.
It still doesn’t choose treatment for every reader. FDA-approved products exist for semaglutide and tirzepatide. A compounded version doesn’t inherit that approval: compounded drugs are not FDA-approved. The exact product matters alongside the ingredient name.
Keep harms on the same page
The semaglutide safety review describes stomach and bowel side effects and an increased risk of gallbladder disease. A benefit doesn’t cancel those burdens. Both belong in a treatment discussion.
The FDA’s account of unapproved weight-loss drugs raises separate quality and safety concerns. Evidence for an approved product cannot answer every question about a different preparation. “Same ingredient” leaves too much unsaid.
Two words to keep apart
similarity
Sharing the word peptide doesn’t give two compounds matching evidence. We look for the same people, preparation, route and outcome. If those don’t match, we say where the comparison stops. A neat list can hide a rather untidy mismatch.
choice
Personal treatment choices need health history, current medicines and a clear goal. A licensed U.S. clinician or prescribing telehealth service can assess U.S. options, including approved products. A doctor or pharmacist can check Australian products and uses. Our questions page helps prepare that conversation.